Labyrinthectomy and Vestibular Neurectomy for Intractable Vertiginous Symptoms
02 December 2016
01 February 2017
31 March 2017 (online)
Introduction Labyrinthectomy and vestibular neurectomy are considered the surgical procedures with the highest possibility of controlling medically untreatable incapacitating vertigo. Ironically, after 100 years of the introduction of both transmastoid labyrinthectomy and vestibular neurectomy, the choice of which procedure to use rests primarily on the evaluation of the hearing and of the surgical morbidity.
Objective To review surgical labyrinthectomy and vestibular neurectomy for the treatment of incapacitating vestibular disorders.
Data Sources PubMed, MD consult and Ovid-SP databases.
Data Synthesis In this review we describe and compare surgical labyrinthectomy and vestibular neurectomy. A contrast between surgical and chemical labyrinthectomy is also examined. Proper candidate selection, success in vertigo control and complication rates are discussed on the basis of a literature review.
Conclusions Vestibular nerve section and labyrinthectomy achieve high and comparable rates of vertigo control. Even though vestibular neurectomy is considered a hearing sparing surgery, since it is an intradural procedure, it carries a greater risk of complications than transmastoid labyrinthectomy. Furthermore, since many patients whose hearing is preserved with vestibular nerve section may ultimately lose that hearing, the long-term value of hearing preservation is not well established. Although the combination of both procedures, in the form of a translabyrinthine vestibular nerve section, is the most certain way to ablate vestibular function for patients with no useful hearing and disabling vertigo, some advocate for transmastoid labyrinthectomy alone, considering that avoiding opening the subarachnoid space minimizes the possible intracranial complications. Chemical labyrinthectomy may be considered a safer alternative, but the risks of hearing loss when hearing preservation is desired are also high.
- 1 Jackler RK, Whinney D. A century of eighth nerve surgery. Otol Neurotol 2001; 22 (03) 401-416
- 2 Molony TB. Decision making in vestibular neurectomy. Am J Otol 1996; 17 (03) 421-424
- 3 Silverstein H, Norrell H, Smouha E, Jones R. Combined retrolab-retrosigmoid vestibular neurectomy. An evolution in approach. Am J Otol 1989; 10 (03) 166-169
- 4 Silverstein H, Wanamaker H, Flanzer J, Rosenberg S. Vestibular neurectomy in the United States--1990. Am J Otol 1992; 13 (01) 23-30
- 5 Quaranta A, Onofri M, Sallustio V, Iurato S. Comparison of long-term hearing results after vestibular neurectomy, endolymphatic mastoid shunt, and medical therapy. Am J Otol 1997; 18 (04) 444-448
- 6 Schlegel M, Vibert D, Ott SR, Häusler R, Caversaccio MD. Functional results and quality of life after retrosigmoid vestibular neurectomy in patients with Ménière's disease. Otol Neurotol 2012; 33 (08) 1380-1385
- 7 Lehnen N, Aw ST, Todd MJ, Halmagyi GM. Head impulse test reveals residual semicircular canal function after vestibular neurectomy. Neurology 2004; 62 (12) 2294-2296
- 8 Sargent EW, Liao E, Gonda Jr RL. Cochlear patency after transmastoid labyrinthectomy for Ménière's syndrome. Otol Neurotol 2016; 37 (07) 937-939
- 9 Heidenreich KD, Griffin GR, Lorenz MB, Telian SA. Transmastoid labyrinthectomy for disabling vertigo in a patient with internal auditory canal pathology. Otol Neurotol 2011; 32 (01) 122-124
- 10 Committee on Hearing and Equilibrium guidelines for the diagnosis and evaluation of therapy in Menière's disease. American Academy of Otolaryngology-Head and Neck Foundation, Inc. Otolaryngol Head Neck Surg 1995; 113 (03) 181-185
- 11 Diaz RC, LaRouere MJ, Bojrab DI, Zappia JJ, Sargent EW, Shaia WT. Quality-of-life assessment of Ménière's disease patients after surgical labyrinthectomy. Otol Neurotol 2007; 28 (01) 74-86
- 12 Badke MB, Pyle GM, Shea T, Miedaner J. Outcomes in vestibular ablative procedures. Otol Neurotol 2002; 23 (04) 504-509
- 13 Eisenman DJ, Speers R, Telian SA. Labyrinthectomy versus vestibular neurectomy: long-term physiologic and clinical outcomes. Otol Neurotol 2001; 22 (04) 539-548
- 14 De La Cruz A, Borne Teufert K, Berliner KI. Transmastoid labyrinthectomy versus translabyrinthine vestibular nerve section: does cutting the vestibular nerve make a difference in outcome?. Otol Neurotol 2007; 28 (06) 801-808
- 15 Hoffmann KK, Silverstein H. Inner ear perfusion: indications and applications. Curr Opin Otolaryngol Head Neck Surg 2003; 11 (05) 334-339
- 16 Beck C, Schmidt CL. 10 years of experience with intratympanally applied streptomycin (gentamycin) in the therapy of Morbus Menière. Arch Otorhinolaryngol 1978; 221 (02) 149-152
- 17 Horii A, Saika T, Uno A. , et al. Factors relating to the vertigo control and hearing changes following intratympanic gentamicin for intractable Ménière's disease. Otol Neurotol 2006; 27 (06) 896-900
- 18 Colletti V, Carner M, Colletti L. Auditory results after vestibular nerve section and intratympanic gentamicin for Ménière's disease. Otol Neurotol 2007; 28 (02) 145-151